KDH Research & Communication
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, KDH Research & Communication sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
KDH Research & Communication: 6 sponsored US clinical trials, 2 recruiting.
KDH Research & Communication sponsors 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 4 completed. The most-studied condition in this pipeline is High-risk, with 1 trials.
Upper-quartile sponsor footprint
KDH Research & Communication sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
Guardians Receiving Information Through Navigators
NCT07147244
Personalized Approach To Habits - Sleep
NCT07029919
Supplying Useful Perimenopause Through Post-menopause Online Resources and Tools
NCT07589335
Monitoring and Outreach for Maternal Safety Postpartum
NCT06899737
Testing Preliminary Effectiveness of a Community Health Worker (CHW) Training Program on Caregiving
NCT06049043
Testing Preliminary Effectiveness of a Training to Support CHWs Outreach on Dental to African American Caregivers
NCT05511935
Therapeutic Areas
What is open in the KDH Research & Communication pipeline
2 recruiting of 6 indexed (33% open); 4 completed (67%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: High-risk (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
KDH Research & Communication: open-pipeline peers nationwide
Peers matched on 6 registered trials and 33% open enrollment, not the therapeutic-area sidebar.
KDH Research & Communication sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 33% open enrollment (± trial volume)
- Aadi Bioscience · 33% recruiting · 9 trials
- Aaron Cook · 33% recruiting · 3 trials
- Abivax S.A. · 33% recruiting · 6 trials
- Actuated Medical · 33% recruiting · 3 trials
Related
What to do with this KDH Research & Communication page
6 registered trials is a research-attention snapshot, not an endorsement of KDH Research & Communication or any single study.
- 2 of KDH Research & Communication's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- High-risk is the condition KDH Research & Communication studies most, compare against other sponsors active in the same condition before evaluating a specific study. See High-risk trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
KDH Research & Communication pipeline card: 6 registered trials from official public datasets.Report a data error.